Cardiac Amyloidosis

USMLE Step 1 trap: Conflates all cardiac amyloidosis with AL type, missing the clinically important ATTR subtype. Cardiac amyloidosis has two major types: AL (from plasma cell dyscrasia, worse prognosis) and ATTR (transthyretin, either hereditary or wild-type senile, more common in elderly men and Black patients).

Cardiac amyloidosis is a restrictive cardiomyopathy caused by extracellular deposition of misfolded amyloid fibrils in the myocardium, and USMLE Step 1 tests it through its paradoxical diagnostic signature: echocardiogram shows increased wall thickness but the ECG shows low-voltage QRS, the opposite of what true hypertrophy produces. Students consistently assume any case of cardiac amyloidosis must be AL type from multiple myeloma, but wild-type ATTR — which requires no plasma cell dyscrasia at all — is actually more prevalent, especially in elderly Black men. The two types that matter for USMLE Step 1 are AL (light-chain, from plasma cell dyscrasias like multiple myeloma) and ATTR (transthyretin, either hereditary TTR mutations or wild-type 'senile' amyloidosis in elderly men, especially Black patients). The distinction between these subtypes, their different etiologies, and their different prognoses is a key exam target — don't treat cardiac amyloidosis as a single disease.

The exam tests this concept at two main levels: knowing the subtypes and which patient populations get which type, and interpreting the classic diagnostic findings. The diagnostic angle is where students lose the most points. USMLE Step 1 loves the paradox of echocardiographic wall thickening combined with low-voltage QRS on ECG — this mismatch is the signature finding and a high-yield discriminator from hypertensive heart disease or HCM, both of which show high voltage. Biopsy findings (Congo red staining, apple-green birefringence under polarized light) are also tested and are highly specific.

What makes this tricky is the counterintuitive ECG-echo dissociation, and the fact that students conflate all amyloidosis with AL type. Wild-type ATTR is actually more common than AL cardiac amyloidosis, particularly in older men — a detail the exam can exploit with clinical vignettes. The biopsy approach is another gap: many students jump straight to endomyocardial biopsy when abdominal fat pad or rectal biopsy with Congo red staining is the standard first step for systemic amyloidosis.

From real student decks

84%have cards covering this topic

62%have mature cards

Common misconceptions

Common mistake

Wrong: Cardiac amyloidosis is always caused by AL (light-chain) amyloid from plasma cell dyscrasias.

Right: Cardiac amyloidosis has two major types: AL (from plasma cell dyscrasia, worse prognosis) and ATTR (transthyretin, either hereditary or wild-type senile, more common in elderly men and Black patients).

AL amyloidosis from plasma cell dyscrasias is the type students learn first, but ATTR cardiac amyloidosis is actually more clinically prevalent, especially in elderly men and Black patients with the hereditary V122I TTR mutation. Wild-type ATTR ('senile cardiac amyloidosis') requires no underlying dyscrasia — transthyretin itself misfolds with aging. When a Step 1 vignette describes an older Black man with restrictive cardiomyopathy and no evidence of myeloma, think ATTR, not AL.

Common mistake

Wrong: Students expect high-voltage ECG complexes in cardiac amyloidosis because the heart is thickened on echo.

Right: Cardiac amyloidosis classically shows low-voltage QRS complexes on ECG despite echocardiographic evidence of increased wall thickness, a key diagnostic clue.

It seems logical that thicker walls should produce bigger ECG deflections — that's how hypertensive heart disease and HCM work. But in amyloidosis, the deposited amyloid fibrils are electrically inert and actually attenuate electrical signal conduction, so wall thickness increases while voltage paradoxically decreases. This low voltage + thick walls combination on echo is the classic Step 1 clue that separates amyloidosis from other causes of ventricular hypertrophy.

Common mistake

Gap: Unaware that fat pad or rectal biopsy with Congo red staining can diagnose amyloidosis without endomyocardial biopsy

Abdominal fat pad biopsy or rectal biopsy stained with Congo red (showing apple-green birefringence under polarized light) is the standard non-cardiac biopsy approach for diagnosing systemic amyloidosis.

Many students assume you need to biopsy the affected organ directly, but for systemic amyloidosis, amyloid deposits diffusely throughout the body — including subcutaneous fat and rectal submucosa. Abdominal fat pad aspiration or rectal biopsy is far less invasive than endomyocardial biopsy and can confirm the diagnosis. The key stain is Congo red, which produces the pathognomonic apple-green birefringence under polarized light — this is a high-yield histology fact for USMLE Step 1.

Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →

Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

Know the two major subtypes of cardiac amyloidosis (AL vs. ATTR), what produces each type of amyloid protein, and which patient populations are at higher risk — including elderly men and Black patients for wild-type ATTR.
Recognize the classic diagnostic dissociation in cardiac amyloidosis: echocardiogram shows increased wall thickness (mimicking hypertrophy), but ECG shows low-voltage QRS complexes — the opposite of what you'd expect in true hypertrophy.
Identify the biopsy approach for systemic amyloidosis: abdominal fat pad or rectal biopsy stained with Congo red, which shows apple-green birefringence under polarized light, and understand that endomyocardial biopsy is not always required.

Can you avoid these mistakes?

A 78-year-old Black man presents with progressive exertional dyspnea and bilateral ankle edema. Echo shows biventricular wall thickening and diastolic dysfunction. His ECG shows low-voltage QRS complexes. SPEP and serum free light chains are normal. What is the most likely type of amyloidosis, and what underlying process causes it?

Why does cardiac amyloidosis produce low-voltage QRS complexes on ECG despite echocardiographic evidence of increased wall thickness? What other conditions cause increased wall thickness, and how does their ECG differ?

A biopsy specimen stained with Congo red shows apple-green birefringence under polarized light. What does this confirm, and from what anatomical site was this biopsy most likely obtained in the workup of systemic amyloidosis?

A 55-year-old woman with known multiple myeloma develops progressive shortness of breath. Echo shows a restrictive pattern. What type of cardiac amyloidosis does she most likely have, and how does its prognosis compare to the type seen in elderly men without a plasma cell dyscrasia?

Cardiac Amyloidosis

Common misconceptions

What the exam tests

Can you avoid these mistakes?

Related topics